# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-028992
Filing Date
2025-02-27
Accepted
2025-02-27 16:00:24
Documents
76
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | crdf-20241231.htm iXBRL | 10-K | 2307620
2 | EX-19.1 | crdf-ex19_1.htm | EX-19.1 | 215310
3 | EX-23.1 | crdf-ex23_1.htm | EX-23.1 | 4988
4 | EX-31.1 | crdf-ex31_1.htm | EX-31.1 | 14128
5 | EX-31.2 | crdf-ex31_2.htm | EX-31.2 | 14009
6 | EX-32.1 | crdf-ex32_1.htm | EX-32.1 | 7974
7 | EX-32.2 | crdf-ex32_2.htm | EX-32.2 | 7855
8 | GRAPHIC | img97750619_0.jpg | GRAPHIC | 99637
| Complete submission text file | 0000950170-25-028992.txt |  | 10418592

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | crdf-20241231.xsd | EX-101.SCH | 1113743
79 | EXTRACTED XBRL INSTANCE DOCUMENT | crdf-20241231_htm.xml | XML | 2065010

Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35558 | Film No.: 25678485
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)